Resilient Biotics
Latest round
- Series A
Last raised
- Dec 2020
Total raised
- $7.2M
Investors
- 5
About Resilient Biotics
Based in North Carolina, US, and founded in 2016, Resilient Biotics Inc. develops microbiome-based live biotherapeutics that decreases or replaces antibiotics in the animal health industry. The company was co-founded by Christopher Belnap, currently its CEO, and Greg Werner. The company's process combines bioinformatics and machine learning tools in identifying new microbial strains and parsing complex microbiome datasets. Resilient Biotics flagship product, RBX001, an intranasal and non-antibiotic treatment that prevent bovine respiratory disease (BRD). The company plans to expand product development around similar non-antibiotic microbiome-derived products for other animals. Resilient Biotics also exploring potential therapeutics for swine and poultry.
Who invested in Resilient Biotics
5 investors across 1 round
See all investors in Resilient Biotics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 2, 2020
Amount
$7.2M
Investors
Questions about Resilient Biotics
Who invested in Resilient Biotics?
Resilient Biotics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Resilient Biotics raised?
Resilient Biotics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Resilient Biotics last raise money?
Resilient Biotics's most recent round on record is a Series A, in Dec 2020.
What does Resilient Biotics do?
Based in North Carolina, US, and founded in 2016, Resilient Biotics Inc.
Where is Resilient Biotics headquartered?
Resilient Biotics is headquartered in Durham, US.
Which VCs invest in companies like Resilient Biotics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Resilient Biotics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Resilient Biotics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.